Načítá se...
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome
There are no proven safe and effective therapies for children who develop life-threatening complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma (CP) has demonstrated potential benefit in adults with SARS-CoV-2, but has theoretical risks.We present the fi...
Uloženo v:
| Vydáno v: | Pediatr Blood Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734626/ https://ncbi.nlm.nih.gov/pubmed/32885904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28693 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|